TAU researchers use gene editing to shrink tumors
5 Articles
5 Articles
CRISPR Therapy Eliminates 50% of Head and Neck Tumors in Preclinical Study
Researchers at Tel Aviv University have demonstrated that CRISPR gene editing can effectively eliminate head and neck tumors by directly injecting lipid nanoparticles (LNPs) carrying CRISPR components into tumors. In a study published in Advanced Science, they reported that 50% of treated tumors disappeared after 84 days, marking a significant advance in precision cancer therapy. Gene editing to collapse cancer cells Head and neck squamous cell …
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage